Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.
View Top Employees from Vivet TherapeuticsWebsite | http://www.vivet-therapeutics.com |
Revenue | $1 million |
Funding | $40.9 million |
Employees | 31 (28 on RocketReach) |
Founded | 2016 |
Address | 80, Boulevard Haussmann, Paris, Île-de-France 75008, FR |
Phone | +33 6 84 75 50 87 |
Technologies |
JavaScript,
HTML,
Google Analytics
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering |
Web Rank | 15 Million |
Keywords | Vivet Therapeutics |
Competitors | Abeona Therapeutics, Adverum Biotechnologies, GenSight Biologics, LYSOGENE, SENSORION |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Vivet Therapeutics employee's phone or email?
The Vivet Therapeutics annual revenue was $1 million in 2024.
Bernard Bénichou is the Chief Medical Officer of Vivet Therapeutics.
28 people are employed at Vivet Therapeutics.
Vivet Therapeutics is based in Paris, Île-de-France.
The NAICS codes for Vivet Therapeutics are [54, 5417, 54171, 541, 541714].
The SIC codes for Vivet Therapeutics are [87, 873].